Company: INV
Filing Date: 2025-05-09
Form Type: 424B3
Source: 0001628280-25-024239
Chunk: 57

Company: Innventure, Inc.
Filing Date: 2025-05-09
Form: 424B3
Chunk 57
---
 time of issuance, the exact magnitude of the dilutive effect cannot be conclusively determined. However, the dilutive effect may be material to our current stockholders. For illustrative purposes only, the table below shows the number of shares of Common Stock that would be issuable upon conversion of Convertible Debentures if we issue securities at an effective price per share that is lower than $10.00 per share, thereby resulting in the issuance of more than 9,415,549 shares of Common Stock. This example is based on the conversion of the original aggregate principal amount of $30.0 million and does not reflect the conversion of any

31

accrued but unpaid interest. As of the Record Date, the outstanding aggregate principal amount of the Convertible Debentures was $20.0 million.

| Assumed Conversion Price |     | Common Stock Issuable Upon Conversion of Convertible Debentures |
| $3.00                    |     |                                                      10,000,000 |
| $4.00                    |     |                                                       7,500,000 |
| $5.00                    |     |                                                       6,000,000 |
| $6.00                    |     |                                                       5,000,000 |
| $7.00                    |     |                                                       4,285,714 |
| $8.00                    |     |                                                       3,750,000 |
| $9.00                    |     |                                                       3,333,333 |
| $10.00                   |     |                                                       3,000,000 |

Consequences of Non-Approval If this Proposal 4 is not approved by our stockholders at the Annual Meeting, we may be required to make monthly prepayments as described above, which may impair our working capital and our ability to fund capital expenditures and operating expenses, including the expenses for the Innventure Companies and the Operating Companies. Our Board has determined that the Securities Purchase Agreement and Convertible Debentures, with such modifications, amendments, or changes (consistent with the intent and purpose of this proposal) agreed upon by the parties thereto, and in accordance with the stockholder approval requirements of Nasdaq Listing Rules 5635(d) and 5635(b), is in the best interests of us and our stockholders because it will decrease the likelihood we will have to make monthly prepayments pursuant to the Convertible Debentures. Furthermore, if this Proposal 4 is not approved by our stockholders at the Annual Meeting, Yorkville will